Apellis Pharmaceuticals, Inc (APLS) insider trading
Every open-market stock purchase and sale by Apellis Pharmaceuticals, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $3.9M over the last 12 months (30 sales). No open-market buys.
- Last insider buy: Morningside Venture Investments Ltd (10% owner), $10M, 4 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $3.9M (30 sales). Last close $41.03 on May 12, 2026.
Recent APLS insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| May 14, 2026 | Cedric Francois (CEO) | Sold (not open market) | $9.1M |
| May 14, 2026 | Cedric Francois (CEO) | Sold (not open market) | $7M |
| May 14, 2026 | Cedric Francois (CEO) | Sold (not open market) | $6.9M |
| May 14, 2026 | Cedric Francois (CEO) | Sold (not open market) | $6.7M |
| May 14, 2026 | Cedric Francois (CEO) | Sold (not open market) | $6M |
| May 14, 2026 | Cedric Francois (CEO) | Sold (not open market) | $5.6M |
| May 14, 2026 | Cedric Francois (CEO) | Sold (not open market) | $4.1M |
| May 14, 2026 | Cedric Francois (CEO) | Sold (not open market) | $3.8M |
| May 14, 2026 | Nur Nicholson (CTO) | Sold (not open market) | $3.4M |
| May 14, 2026 | Timothy Eugene Sullivan (CFO) | Sold (not open market) | $3.1M |
| May 14, 2026 | Leslie Meltzer (Officer) | Sold (not open market) | $2.6M |
| May 14, 2026 | Pascal Deschatelets (C-suite exec) | Sold (not open market) | $2.5M |
| May 14, 2026 | Caroline Baumal (C-suite exec) | Sold (not open market) | $2.5M |
| May 14, 2026 | Caroline Baumal (C-suite exec) | Sold (not open market) | $2.5M |
| May 14, 2026 | Timothy Eugene Sullivan (CFO) | Sold (not open market) | $2.3M |
| May 14, 2026 | David O. Watson (General Counsel) | Sold (not open market) | $2.3M |
| May 14, 2026 | Timothy Eugene Sullivan (CFO) | Sold (not open market) | $2.3M |
| May 14, 2026 | Timothy Eugene Sullivan (CFO) | Sold (not open market) | $2.3M |
| May 14, 2026 | Timothy Eugene Sullivan (CFO) | Sold (not open market) | $2.1M |
| May 14, 2026 | Pascal Deschatelets (C-suite exec) | Sold (not open market) | $2M |
| May 14, 2026 | Timothy Eugene Sullivan (CFO) | Sold (not open market) | $2M |
| May 14, 2026 | Nur Nicholson (CTO) | Sold (not open market) | $2M |
| May 14, 2026 | David O. Watson (General Counsel) | Sold (not open market) | $2M |
| May 14, 2026 | David O. Watson (General Counsel) | Sold (not open market) | $2M |
| May 14, 2026 | Nur Nicholson (CTO) | Sold (not open market) | $1.9M |
Who's trading APLS
- Caroline Baumal, C-suite exec: sold $175K (3 sales), last May 14, 2026
- Kelley Boucher, C-suite exec: other filings, last May 14, 2026
- Gerald Chan, Insider: other filings, last May 14, 2026
- James George Chopas, C-suite exec: sold $78.7K (3 sales), last May 14, 2026
- Mark Jeffrey DeLong, Officer: sold $147K (4 sales), last May 14, 2026
- Pascal Deschatelets, C-suite exec: sold $198K (3 sales), last May 14, 2026
- Mikael Dolsten, Insider: other filings, last May 14, 2026
- A. Sinclair Dunlop, Insider: sold $738K (1 sale), last May 14, 2026
- Timothy Eugene Sullivan, CFO: sold $647K (4 sales), last May 14, 2026
- Craig A Wheeler, Insider: other filings, last May 14, 2026
- Keli Walbert, Insider: other filings, last May 14, 2026
- David O. Watson, General Counsel: sold $697K (6 sales), last May 14, 2026
- Paul R. Fonteyne, Insider: other filings, last May 14, 2026
- Cedric Francois, CEO: sold $980K (3 sales), last May 14, 2026
- Leslie Meltzer, Officer: other filings, last May 14, 2026
Get free alerts when an insider at Apellis Pharmaceuticals, Inc files a new trade →